TD Cowen analyst Yaron Werber maintained a Buy rating on Roivant Sciences (ROIV – Research Report) today. The company’s shares ...

As Donald Trump secures the 2024 U.S. presidency, prominent Indian-Americans, including Sundar Pichai, Satya Nadella, and Nikki Haley, share their congratulations and optimism for the future. These ...

AB-101-001 is a Phase 1a/1b double-blind, randomized, placebo-controlled clinical trial designed to investigate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of single- ...

Strive Enterprises, a financial services company co-founded by former Republican presidential candidate Vivek Ramaswamy, has announced plans to move its headquarters to Dallas.

Organon, which is seeking approval of Vtama as a treatment for atopic dermatitis, said the FDA set a new target action date of March 12 for a decision after requesting the final datasets and ...

The U.S. is deploying a total of six nuclear equipped B-52s, an additional squadron of F-15E Strike Eagles, and more aerial ...

Check the time stamp on this data. Updated AI-Generated Signals for Roivant Sciences Ltd. (ROIV) available here: ROIV.

Strive Enterprises, co-founded by the former Republican presidential candidate, is also launching a wealth management ...

HanAll records revenue of 36.8 billion KRW in the third quarter, with an operating profit of 430 million KRW. Results for the ...

An Expert View from Cumulus Oncology about its innovative business model, which is all about improving the efficiency of drug ...

Running her second campaign for Congress, Rebecca Cooke has raised more than $5.3 million through the final reporting period, ...

Organon has completed the acquisition of Dermavant Sciences, a subsidiary of Roivant, expanding its dermatology portfolio. With the deal's closure, Organon has added Dermavant’s VTAMA (tapinarof) ...